Animal Models of Tissue Characterization of Area at Risk, Edema and Fibrosis

Current Cardiovascular Imaging Reports

Volumn 7, Issue 4, 2014, Pages 1-10

  Fernández Jiménez, Rodrigo ^a,b   Fernández Friera, Leticia ^a,c   Sánchez González, Javier ^a,d   Ibáñez, Borja ^a,b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Hospital Universitario HM Montepríncipe   (Spain)

^d PHILIPS HEALTHCARE   (United States)

Author keywords

Animal model; Area at risk; Edema; Fibrosis; Magnetic resonance

Indexed keywords

13C PYRUVATE; CONTRAST MEDIUM; GADOLINIUM; UNCLASSIFIED DRUG;

CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; DIFFUSION TENSOR IMAGING; HEART EDEMA; HEART MUSCLE FIBROSIS; HUMAN; INFARCTION; NONHUMAN; REVIEW; TISSUE CHARACTERIZATION;

EID: 84897093872     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-014-9259-z     Document Type: Review

References (96)

1. Dobrucki LW, Sinusas AJ. PET and SPECT in cardiovascular molecular imaging. Nat Rev Cardiol. 2010;7: 38-47.
2. Nacif MS, Kawel N, Lee JJ, et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology. 2012;264: 876-83.
3. Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121: 692-705.
4. Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15: 91.
5. Ordovas KG, Higgins CB. Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology. 2011;261: 358-74.
6. Kramer CM, Narula J. CMR imaging: creating contrast without cosmetics. JACC Cardiovasc Imaging. 2011;4: 1326-7.
7. Garcia-Dorado D, Andres-Villarreal M, Ruiz-Meana M, et al. Myocardial edema: a translational view. J Mol Cell Cardiol. 2012;52: 931-9.
8. Azevedo CF, Nigri M, Higuchi ML, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56: 278-87.
9. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309: 896-908.
10. Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60: 408-20.
11. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56: 867-74.
12. Shiozaki AA, Senra T, Arteaga E, et al. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. J Cardiovasc Comput Tomogr. 2013;7: 173-81.
13. Fernandez-Jimenez R, Lopez-Romero P, Suarez-Barrientos A, et al. Troponin release overestimates infarct size in presence of left ventricular hypertrophy. J Am Coll Cardiol. 2012;60: 640-1.
14. Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128: 814-22.
15. Rijzewijk LJ, van der Meer RW, Smit JW, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52: 1793-9.
16. Wong CX, Abed HS, Molaee P, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57: 1745-51.
17. Schuster A, Grunwald I, Chiribiri A, et al. An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques. J Cardiovasc Magn Reson. 2010;12: 53.
18. Ibanez B, Macaya C, Sanchez-Brunete V, et al. Effect of early metoprolol on infarct size in st-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) Trial. Circulation. 2013;128: 1495-503.
19. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomized trial. Lancet. 2010;375: 727-34.
20. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 2013;381: 166-75.
21. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359: 473-81.
22. Friedrich MG, Abdel-Aty H, Taylor A, et al. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51: 1581-7.
23. Ibanez B, Prat-Gonzalez S, Speidl WS, et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation. 2007;115: 2909-16.
24. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006;113: 1865-70. Pioneer study in dogs demonstrating that edema imaging by T2-weighted cardiac magnetic resonance is a useful tool for retrospectively delineating the area at risk in reperfused myocardial infarction.
25. Garcia-Dorado D, Oliveras J, Gili J, et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993;27: 1462-9.
26. Tilak GS, Hsu LY, Hoyt Jr RF, et al. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol. 2008;43: 7-15.
27. Boxt LM, Hsu D, Katz J, et al. Estimation of myocardial water content using transverse relaxation time from dual spin-echo magnetic resonance imaging. Magn Reson Imaging. 1993;11: 375-83.
28. Higgins CB, Herfkens R, Lipton MJ, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983;52: 184-8.
29. Jennings RB, Schaper J, Hill ML, et al. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res. 1985;56: 262-78.
30. Carlsson M, Ubachs JF, Hedstrom E, et al. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging. 2009;2: 569-76.
31. Arai AE, Leung S, Kellman P. Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction. Radiology. 2012;265: 23-32. Excellent controversy showing arguments in favor of the used of T2-weighted imaging for delineating the area at risk in ischemic myocardial injury.
32. Croisille P, Kim HW, Kim RJ. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology. 2012;265: 12-22. Excellent controversy showing arguments against the used of T2-weighted imaging for delineating the area at risk in ischemic myocardial injury.
33. Friedrich MG, Kim HW, Kim RJ. T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging. 2011;4: 1014-21.
34. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14: 42.
35. Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011;4: 269-78.
36. Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5: 596-603.
37. Ghugre NR, Ramanan V, Pop M, et al. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI. Magn Reson Med. 2011;66: 1129-41.
38. Mewton N, Rapacchi S, Augeul L, et al. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model. Basic Res Cardiol. 2011;106: 1247-57.
39. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356: 1140-51.
40. Friedrich J, Apstein CS, Ingwall JS. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart. Circulation. 1995;92: 3527-38.
41. Bottomley PA, Weiss RG. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology. 2001;219: 411-8.
42. Schroeder MA, Clarke K, Neubauer S, et al. Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease. Circulation. 2011;124: 1580-94.
43. Merritt ME, Harrison C, Storey C, et al. Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3. Magn Reson Med. 2008;60: 1029-36.
44. Schroeder MA, Swietach P, Atherton HJ, et al. Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study. Cardiovasc Res. 2010;86: 82-91.
45. Golman K, Petersson JS, Magnusson P, et al. Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med. 2008;59: 1005-13.
46. Tsaftaris SA, Zhou X, Tang R, et al. Detecting myocardial ischemia at rest with cardiac phase-resolved blood oxygen level-dependent cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2013;6: 311-9.
47. Akhtar AM, Schneider JE, Chapman SJ, et al. In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging. PLoS One. 2010;5: e12800.
48. McAteer MA, Sibson NR, von Zur MC, et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med. 2007;13: 1253-8.
49. Grieve SM, Lonborg J, Mazhar J, et al. Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury. Eur Biophys J. 2013;42: 61-70.
50. Kellman P, Aletras AH, Mancini C, et al. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared with turbo spin echo. Magn Reson Med. 2007;57: 891-7.
51. Kumar A, Beohar N, Arumana JM, et al. CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession. JACC Cardiovasc Imaging. 2011;4: 1265-73.
52. Zhou X, Rundell V, Liu Y, et al. On the mechanisms enabling myocardial edema contrast in bSSFP-based imaging approaches. Magn Reson Med. 2011;66: 187-91.
53. Crick SJ, Sheppard MN, Ho SY, et al. Anatomy of the pig heart: comparisons with normal human cardiac structure. J Anat. 1998;193(Pt 1): 105-19.
54. Weaver ME, Pantely GA, Bristow JD, et al. A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovasc Res. 1986;20: 907-17.
55. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987;21: 737-46. In vivo evaluation of the coronary collateral circulation in eight animal species (dog, cat, rat, guinea pig, ferret, baboon, rabbit, pig), a critical determinant of the rate of myocardial necrosis progression resulting from experimental coronary artery occlusion.
56. White FC, Carroll SM, Magnet A, et al. Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992;71: 1490-500.
57. Castanares-Zapatero D, Bouleti C, Sommereyns C, et al. Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the alpha1AMP-activated protein kinase isoform. Crit Care Med. 2013;41(12): e411-22. doi: 10. 1097/CCM. 0b013e31829866dc.
58. Smeding L, Plotz FB, Lamberts RR, et al. Mechanical ventilation with high tidal volumes attenuates myocardial dysfunction by decreasing cardiac edema in a rat model of LPS-induced peritonitis. Respir Res. 2012;13: 23.
59. Smeding L, Leong-Poi H, Hu P, et al. Salutary effect of resveratrol on sepsis-induced myocardial depression. Crit Care Med. 2012;40: 1896-907.
60. Dongaonkar RM, Stewart RH, Quick CM, et al. Award article: Microcirculatory Society Award for Excellence in Lymphatic Research: time course of myocardial interstitial edema resolution and associated left ventricular dysfunction. Microcirculation. 2012;19: 714-22.
61. Cruz-Adalia A, Jimenez-Borreguero LJ, Ramirez-Huesca M, et al. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation. 2010;122: 1396-404.
62. Luna A, Sánchez-González J, Caro P. Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin N Am. 2011;19: 69-94.
63. Okayama S, Uemura S, Watanabe M, et al. Novel application of black-blood echo-planar imaging to the assessment of myocardial infarction. Heart Vessels. 2010;25: 104-12.
64. Jansen MA, van Emous JG, Nederhoff MG, et al. Assessment of myocardial viability by intracellular 23Na magnetic resonance imaging. Circulation. 2004;110: 3457-64.
65. Constantinides CD, Kraitchman DL, O'Brien KO, et al. Noninvasive quantification of total sodium concentrations in acute reperfused myocardial infarction using 23Na MRI. Magn Reson Med. 2001;46: 1144-51.
66. Kim RJ, Judd RM, Chen EL, et al. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation. 1999;100: 185-92.
67. Ouwerkerk R, Bottomley PA, Solaiyappan M, et al. Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study. Radiology. 2008;248: 88-96.
68. Aguor EN, van de Kolk CW, Arslan F, et al. 23Na chemical shift imaging and Gd enhancement of myocardial edema. Int J Cardiovasc Imaging. 2013;29: 343-54.
69. Green JJ, Berger JS, Kramer CM, et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2012;5: 370-7.
70. Rathod RH, Prakash A, Powell AJ, et al. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol. 2010;55: 1721-8.
71. Sato A, Nozato T, Hikita H, et al. Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction. J Am Coll Cardiol. 2012;59: 730-8.
72. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42: 895-901.
73. Gerber BL, Garot J, Bluemke DA, et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106: 1083-9.
74. Ingkanisorn WP, Rhoads KL, Aletras AH, et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol. 2004;43: 2253-9.
75. Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58: 1271-9.
76. Schelbert EB, Hsu LY, Anderson SA, et al. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging. 2010;3: 743-52.
77. McDowell KS, Arevalo HJ, Maleckar MM, et al. Susceptibility to arrhythmia in the infarcted heart depends on myofibroblast density. Biophys J. 2011;101: 1307-15.
78. Ng J, Jacobson JT, Ng JK, et al. Virtual electrophysiological study in a 3-dimensional cardiac magnetic resonance imaging model of porcine myocardial infarction. J Am Coll Cardiol. 2012;60: 423-30.
79. Filgueiras-Rama D, Price NF, Martins RP, et al. Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium. Circ Arrhythm Electrophysiol. 2012;5: 1160-7.
80. McGann CJ, Kholmovski EG, Oakes RS, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008;52: 1263-71.
81. Cooper LL, Odening KE, Hwang MS, et al. Electromechanical and structural alterations in the aging rabbit heart and aorta. Am J Physiol Heart Circ Physiol. 2012;302: H1625-35.
82. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52: 1574-80.
83. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122: 138-44.
84. Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6: 475-84.
85. Zhang M, Takimoto E, Hsu S, et al. Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. J Am Coll Cardiol. 2010;56: 2021-30.
86. Coelho-Filho OR, Mongeon FP, Mitchell R, et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging. 2013;6: 134-41.
87. Messroghli DR, Nordmeyer S, Dietrich T, et al. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping. Circ Cardiovasc Imaging. 2011;4: 636-40.
88. Stedman HH, Sweeney HL, Shrager JB, et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 1991;352: 536-9.
89. Messroghli DR, Nordmeyer S, Buehrer M, et al. Small animal Look-Locker inversion recovery (SALLI) for simultaneous generation of cardiac T1 maps and cine and inversion recovery-prepared images at high heart rates: initial experience. Radiology. 2011;261: 258-65.
90. Garcia-Alvarez A, Fernandez-Friera L, Garcia-Ruiz JM, et al. Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance. J Am Coll Cardiol. 2013;62: 1621-31.
91. Hadri L, Kratlian RG, Benard L, et al. Therapeutic efficacy of AAV1. SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation. 2013;128: 512-23.
92. Holmes AA, Scollan DF, Winslow RL. Direct histologic validation of diffusion tensor MRI in formaldehyde-fixed myocardium. Magn Reson Med. 2000;44: 157-61.
93. Pop M, Ghugre NR, Ramanan V, et al. Quantification of fibrosis in infarcted swine hearts by ex vivo late gadolinium-enhancement and diffusion-weighted MRI methods. Phys Med Biol. 2013;58: 5009-28.
94. Wu EX, Wu Y, Nicholls JM, et al. MR diffusion tensor imaging study of postinfarct myocardium structural remodeling in a porcine model. Magn Reson Med. 2007;58: 687-95.
95. Jaffer FA, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation. 2007;116: 1052-61.
96. Su H, Spinale FG, Dobrucki LW, et al. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation. 2005;112: 3157-67.